Treatments such as intranasal glucocorticoids and sinus surgery provide limited long-term relief and fail to address the underlying inflammatory mechanisms. Biologic therapies targeting ...

Importantly, TEZSPIRE significantly reduced the need for subsequent nasal polyp surgery by 98% and the need for systemic corticosteroid treatment by 88% compared to placebo. TEZSPIRE was generally ...